These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38788885)
1. IL-27 promotes pathogenic T cells in a mouse model of Sjögren's disease. Debreceni IL; Barr JY; Upton EM; Chen YG; Lieberman SM Clin Immunol; 2024 Jul; 264():110260. PubMed ID: 38788885 [TBL] [Abstract][Full Text] [Related]
2. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome. Barr JY; Wang X; Meyerholz DK; Lieberman SM Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508 [TBL] [Abstract][Full Text] [Related]
3. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma. Pontarini E; Murray-Brown WJ; Croia C; Lucchesi D; Conway J; Rivellese F; Fossati-Jimack L; Astorri E; Prediletto E; Corsiero E; Romana Delvecchio F; Coleby R; Gelbhardt E; Bono A; Baldini C; Puxeddu I; Ruscitti P; Giacomelli R; Barone F; Fisher B; Bowman SJ; Colafrancesco S; Priori R; Sutcliffe N; Challacombe S; Carlesso G; Tappuni A; Pitzalis C; Bombardieri M Ann Rheum Dis; 2020 Dec; 79(12):1588-1599. PubMed ID: 32963045 [TBL] [Abstract][Full Text] [Related]
4. The Ratio of Blood T Follicular Regulatory Cells to T Follicular Helper Cells Marks Ectopic Lymphoid Structure Formation While Activated Follicular Helper T Cells Indicate Disease Activity in Primary Sjögren's Syndrome. Fonseca VR; Romão VC; Agua-Doce A; Santos M; López-Presa D; Ferreira AC; Fonseca JE; Graca L Arthritis Rheumatol; 2018 May; 70(5):774-784. PubMed ID: 29361207 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells. Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724 [TBL] [Abstract][Full Text] [Related]
6. CCR9/CXCR5 Co-Expressing CD4 T Cells Are Increased in Primary Sjögren's Syndrome and Are Enriched in PD-1/ICOS-Expressing Effector T Cells. Hinrichs AC; Kruize AA; Lafeber FPJG; Leavis HL; van Roon JAG Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569326 [TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice. Debreceni IL; Chimenti MS; Serreze DV; Geurts AM; Chen YG; Lieberman SM Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322152 [TBL] [Abstract][Full Text] [Related]
8. Sirolimus therapy restores the PD-1+ICOS+Tfh:CD45RA-Foxp3 Wang Y; Guo H; Liang Z; Feng M; Wu Y; Qin Y; Zhao X; Gao C; Liu G; Luo J Mol Immunol; 2022 Jul; 147():90-100. PubMed ID: 35523039 [TBL] [Abstract][Full Text] [Related]
9. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis. Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456 [TBL] [Abstract][Full Text] [Related]
10. IL-27 Regulated CD4 Qi J; Zhang Z; Tang X; Li W; Chen W; Yao G Front Immunol; 2020; 11():1699. PubMed ID: 32849596 [TBL] [Abstract][Full Text] [Related]
11. Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome. Gong YZ; Nititham J; Taylor K; Miceli-Richard C; Sordet C; Wachsmann D; Bahram S; Georgel P; Criswell LA; Sibilia J; Mariette X; Alsaleh G; Gottenberg JE J Autoimmun; 2014 Jun; 51():57-66. PubMed ID: 24411167 [TBL] [Abstract][Full Text] [Related]
12. Achaete-scute complex homologue 2 accelerates the development of Sjögren's syndrome-like disease in the NOD/ShiLtJ mouse. Kim SM; Kwon JE; Park JS; Seo HB; Jung KA; Moon YM; Lee J; Kwok SK; Cho ML; Park SH Immunol Lett; 2017 Oct; 190():26-33. PubMed ID: 28728856 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice. Allred MG; Chimenti MS; Ciecko AE; Chen YG; Lieberman SM Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916486 [TBL] [Abstract][Full Text] [Related]
14. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background. Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176 [TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168 [TBL] [Abstract][Full Text] [Related]
16. Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease. Mostafa S; Seamon V; Azzarolo AM Exp Eye Res; 2012 Mar; 96(1):88-97. PubMed ID: 22227485 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-27 Is Essential for Type 1 Diabetes Development and Sjögren Syndrome-like Inflammation. Ciecko AE; Foda B; Barr JY; Ramanathan S; Atkinson MA; Serreze DV; Geurts AM; Lieberman SM; Chen YG Cell Rep; 2019 Dec; 29(10):3073-3086.e5. PubMed ID: 31801074 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice. Park E; Kim D; Lee SM; Jun HS Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477 [TBL] [Abstract][Full Text] [Related]
19. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome. Lieberman SM; Kreiger PA; Koretzky GA Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706 [TBL] [Abstract][Full Text] [Related]
20. IL-4-dependent effector phase in autoimmune exocrinopathy as defined by the NOD.IL-4-gene knockout mouse model of Sjögren's syndrome. Brayer JB; Cha S; Nagashima H; Yasunari U; Lindberg A; Diggs S; Martinez J; Goa J; Humphreys-Beher MG; Peck AB Scand J Immunol; 2001; 54(1-2):133-40. PubMed ID: 11439159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]